97 / 100
T
he
role
of
oxidative
stress
on
the
pathophysiology
of
metabolic
syndrome
R
ev
A
ssoc
M
ed
B
ras
2017; 63(1):85-91
91
bioavailability and their protective role in humans. Mol Nutr Food Res.
2009; 53(Suppl 2):S194-218.
34.
Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215(2):213-9.
35.
Sies H. Oxidative stress: from basic research to clinical application. Am J
Med. 1991; 91(3C):31S-8S.
36.
Mangge H, Becker K, Fuchs D, Gostner JM. Antioxidants, inflammation
and cardiovascular disease. World J Cardiol. 2014; 6(6):462-77.
37.
Fiedor J, Burda K. Potential role of carotenoids as antioxidants in human
health and disease. Nutrients. 2014; 6(2):466-88.
38.
Moreto F, Kano HT, Torezan GA, de Oliveira EP, Manda RM, Teixeira O,
et al. Changes in malondialdehyde and C-reactive protein concentrations
after lifestyle modification are related to different metabolic syndrome-
associated pathophysiological processes. Diabetes Metab Syndr. 2015;
9(4):218-22.
39.
Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim Biophys
Acta. 2014; 1840(2):809-17.
40.
Petramala L, Pignatelli P, Carnevale R, Zinnamosca L, Marinelli C,
Settevendemmie A, et al. Oxidative stress in patients affected by primary
aldosteronism. J Hypertens. 2014; 32(10):2022-9; discussion 2029.
41.
Basu S. Bioactive eicosanoids: role of prostaglandin F(2alpha) and F(2)-
isoprostanes in inflammation and oxidative stress related pathology. Mol
Cells.; 30(5):383-91.
42.
Reis GS, Augusto VS, Silveira AP, Jordão AA Jr, Baddini-Martinez J, Poli
Neto O, et al. Oxidative-stress biomarkers in patients with pulmonary
hypertension. Pulm Circ. 2013; 3(4):856-61.
43.
Davies SS, Roberts LJ 2nd. F2-isoprostanes as an indicator and risk factor
for coronary heart disease. Free Radic Biol Med. 2011; 50(5):559-66.
44.
Fraga CG, Oteiza PI, Galleano M. In vitro measurements and interpretation
of total antioxidant capacity. Biochim Biophys Acta. 2014; 1840(2):931-4.
45.
Beretta G, Aldini G, Facino RM, Russell RM, Krinsky NI, Yeum KJ. Total
antioxidant performance: a validated fluorescence assay for the measurement
of plasma oxidizability. Anal Biochem. 2006; 354(2):290-8.
46.
Shacter E. Quantification and significance of protein oxidation in biological
samples. Drug Metab Ver. 2000; 32(3-4):307-26.
47.
Prado RP, dos Santos BF, Pinto CL, de Assis KR, Salvadori DM, Ladeira MS.
Influence of diet on oxidative DNA damage, uracil misincorporation and
DNA repair capability. Mutagenesis. 2010; 25(5):483-7.
48. Collins AR, Gedik CM, Olmedilla B, Southon S, Bellizzi M. Oxidative DNA
damage measured in human lymphocytes: large differences between sexes
and between countries, and correlations with heart disease mortality rates.
FASEB J. 1998; 12(13):1397-400.
49.
Novak EM, Keller BO, Innis SM. Dietary lipid quality and long-term
outcome. Nestle Nutr Workshop Ser Pediatr Program. 2011; 68:17-27;
discussion 27-32.
50.
Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le
M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes.
2013; 62(10):3307-15.
51.
Keller U. Dietary proteins in obesity and in diabetes. Int J Vitam Nutr Res.
2011; 81(2-3):125-33.
52. Castro-Quezada I, Román-Viñas B, Serra-Majem L. The Mediterranean diet
and nutritional adequacy: a review. Nutrients. 2014; 6(1):231-48.
53. Casas R, Sacanella E, Estruch R. The immune protective effect of the
Mediterranean diet against chronic low-grade inflammatory diseases. Endocr
Metab Immune Disord Drug Targets. 2014; 14(4):245-54.
54.
Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA,
Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome
and its components: a meta-analysis of 50 studies and 534,906 individuals.
J Am Coll Cardiol. 2011; 57(11):1299-313.
55.
Salas-Salvadó J, Bulló M, Babio N, Martínez-González MÁ, Ibarrola-Jurado
N, Basora J, et al. Reduction in the incidence of type 2 diabetes with the
Mediterranean diet: results of the PREDIMED-Reus nutrition intervention
randomized trial. Diabetes Care. 2011; 34(1):14-9.
56.
Doménech M, Roman P, Lapetra J, García de la Corte FJ, Sala-Vila A, de la
Torre R, et al. Mediterranean diet reduces 24-hour ambulatory blood pressure,
blood glucose, and lipids: one-year randomized, clinical trial. Hypertension.
2014; 64(1):69-76.
57. Vincent-Baudry S, Defoort C, Gerber M, Bernard MC, Verger P, Helal O, et
al. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors
after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet.
Am J Clin Nutr. 2005; 82(5):964-71.
58.
Mitjavila MT, Fandos M, Salas-Salvadó J, Covas MI, Borrego S, Estruch R,
et al. The Mediterranean diet improves the systemic lipid and DNA oxidative
damage in metabolic syndrome individuals. A randomized, controlled, trial.
Clin Nutr. 2013; 32(2):172-8.
59. Golbidi S, Mesdaghinia A, Laher I. Exercise in the metabolic syndrome. Oxid
Med Cell Longev. 2012; 2012:349710.
60.
Huang CJ, McAllister MJ, Slusher AL, Webb HE, Mock JT, Acevedo EO.
Obesity-related oxidative stress: the impact of physical activity and diet
manipulation. Sports Med Open. 2015; 1:32.
61.
Phillips MD, Patrizi RM, Cheek DJ, Wooten JS, Barbee JJ, Mitchell JB. Resistance
training reduces subclinical inflammation in obese, postmenopausal women.
Med Sci Sports Exerc. 2012; 44(11):2099-110.
62. Oh S, Tanaka K, Warabi E, Shoda J. Exercise reduces inflammation and
oxidative stress in obesity-related liver diseases. Med Sci Sports Exerc. 2013;
45(12):2214-22.
63.
Shin YA, Lee JH, Song W, Jun TW. Exercise training improves the antioxidant
enzyme activity with no changes of telomere length. Mech Ageing Dev. 2008;
129(5):254-60.